Benefit of millisecond waveform durations for patients with high defibrillation thresholds

Heart Rhythm : the Official Journal of the Heart Rhythm Society
Russell A DenmanHelen E Burnett

Abstract

Patients with a high defibrillation threshold (DFT) present an atypical but vexing problem with regard to implantable cardioverter-defibrillator (ICD) therapy. Their implant procedures are lengthy and involve more risk of complications. These patients often sustain a reduced safety margin that may compromise their survival. The purpose of this study was to evaluate the use of fixed millisecond duration model-optimized biphasic waveforms compared with conventional tilt-based waveforms in patients having a high DFT. We compared a 65%/65% tilt biphasic waveform to a millisecond duration biphasic waveform based on the biphasic burping theory using a 90-microF shock capacitor. Fifty-four patients were evaluated. Mean DFT with tilt was reduced from 11.0 +/- 5.5 J to 8.8 +/- 4.1 J, for a mean reduction of 20% (P < .0001). For the 13 patients with tilt-based DFTs > or = 15 J, DFT was reduced from 18.7 +/- 4.1 J to 13.4 +/- 3.5 J, for a mean DFT reduction of 28% (P = .009). The population peak DFT was reduced from 29.0 J to 17.5 J, for a 41% reduction (P = .03). Use of simple millisecond biphasic waveforms instead of conventional tilt-based waveforms can lead to substantial reductions in DFT, especially in patients with high DFT.

References

Nov 11, 1991·Pacing and Clinical Electrophysiology : PACE·I SingerJ Kupersmith
Nov 1, 1988·Pacing and Clinical Electrophysiology : PACE·T ChurchW Watson
Nov 1, 1971·IEEE Transactions on Bio-medical Engineering·J C SchuderP Y Keskar
Sep 1, 1995·Journal of the American College of Cardiology·D SchwartzmanF E Marchlinski
Apr 1, 1993·Pacing and Clinical Electrophysiology : PACE·M W Kroll
Nov 1, 1994·Pacing and Clinical Electrophysiology : PACE·M W Kroll
Sep 1, 1995·Journal of Cardiovascular Electrophysiology·G P WalcottR E Ideker
Oct 24, 1998·Journal of Cardiovascular Electrophysiology·T TokanoS A Strickberger
May 11, 1999·Pacing and Clinical Electrophysiology : PACE·A A MehdiradM W Kroll
Aug 25, 1999·Annals of Emergency Medicine·J B WhiteR E Ideker
Mar 3, 2001·Pacing and Clinical Electrophysiology : PACE·M O SweeneyP Degroot
Aug 22, 2001·Journal of Cardiovascular Electrophysiology·A E LindblomN A Trayanova
Feb 16, 2002·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·K A MowreyR Efimov
Apr 11, 2003·Pacing and Clinical Electrophysiology : PACE·Himanshu H ShuklaDavid Roberts
Jan 15, 2004·Pacing and Clinical Electrophysiology : PACE·Arjun D SharmaZiaozheng Zhang
Oct 30, 2004·Pacing and Clinical Electrophysiology : PACE·Klaus KetteringVolker Kühlkamp
Feb 1, 2005·Pacing and Clinical Electrophysiology : PACE·Maria I Anastasiou-NanaJohn N Nanas
Apr 27, 2005·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Edward P Gerstenfeld

❮ Previous
Next ❯

Citations

Nov 30, 2011·Herzschrittmachertherapie & Elektrophysiologie·D ErkapicJ Ehrlich
Jun 2, 2007·Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing·Mark W Kroll, Charles D Swerdlow
Apr 18, 2013·Current Treatment Options in Cardiovascular Medicine·Maria Vittoria Matassini, Jeff S Healey
Jan 6, 2010·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Jesus E Val-Mejias, Ashish Oza
Aug 5, 2008·Biomedical Engineering Online·Derek J Dosdall, James D Sweeney
Oct 23, 2008·Expert Review of Cardiovascular Therapy·Eric R UyguancoJohn Kassotis
Mar 4, 2008·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Michael GoldAshish Oza
May 9, 2009·Pacing and Clinical Electrophysiology : PACE·Michael R GoldKenneth A Ellenbogen
Apr 28, 2007·Pacing and Clinical Electrophysiology : PACE·Charles D SwerdlowPaul J Degroot
Apr 28, 2007·Pacing and Clinical Electrophysiology : PACE·David KeaneMark K Kroll
Feb 17, 2007·Pacing and Clinical Electrophysiology : PACE·Senthil NatarajanAshish Oza
Sep 28, 2007·Pacing and Clinical Electrophysiology : PACE·Werner Irnich
May 17, 2007·Journal of Cardiovascular Electrophysiology·Giuseppe BorianiMark W Kroll
Aug 8, 2008·Pacing and Clinical Electrophysiology : PACE·Niraj Varma, Igor Efimov
Jul 30, 2011·Pacing and Clinical Electrophysiology : PACE·Karel Smits, Nathalie Virag
Jan 7, 2011·Pacing and Clinical Electrophysiology : PACE·William E SandersRaymond E Ideker
Aug 22, 2012·Pacing and Clinical Electrophysiology : PACE·Shephal K DoshiJesus E Val-Mejias
Dec 13, 2006·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Karlheinz SeidlMark W Kroll
Sep 2, 2006·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Werner Irnich
Sep 2, 2006·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Charles D Swerdlow
Feb 2, 2013·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Karel SmitsCharles D Swerdlow
Dec 18, 2016·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Niraj VarmaAshish Oza
Dec 16, 2021·Journal of Cardiovascular Electrophysiology·Karam Ayoub, Travis Richardson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Cajal Bodies & Gems

Cajal bodies or coiled bodies are dense foci of coilin protein. Gemini of Cajal bodies, or gems, are microscopically similar to Cajal bodies. It is believed that Cajal bodies play important roles in RNA processing while gems assist the Cajal bodies. Find the latest research on Cajal bodies and gems here.